Molecular Pathology Laboratory Network

Trichomonas Vaginalis Featured

Test Code
TV
Associations
Vaginitis
Methodology
Aptima Combo(R) 2 by Transcription-Mediated Amplification (TMA)
CPT Codes
87798
Turnaround Time
2-5 days
Specimen Requirements
  • 3.0 mL ThinPrep® PAP media
  • 3.0 mL SurePath media
  • 1.0 mL liquid cytology media (ThinPrep) media transferred to APTIMA specimen transfer (GREEN) tube
  • One cervical or urethral swab collected with APTIMA Unisex Swab Specimen Collection Kit (blue swab)
  • 20.0-30.0 mL (first catch) urine (female) collected in preservative-free urine collection cup or 2.0 mL urine transferred to APTIMA urine specimen transport (YELLOW) tube
Specimen Stability
  • ThinPrep - 14 days from collection
  • Swabs - 60 days from collection
  • Urine - 24 hours from collection; 30 days after transfer to APTIMA urine transport (YELLOW) tube
Storage & Handling
Transport and store all specimens at 2-30°C
Causes for Rejection
  • Insufficient specimen volume
  • No swab in transport tube
  • Urine specimens >24 hours old unless transferred to APTIMA urine transport (YELLOW) tube
  • Reference Range
    Detected/Not Detected
    Related Content
    Trichomonas vaginalis is a sexually transmitted parasite that can cause vaginitis, urethritis, premature membrane rupture in pregnancy, and makes women more susceptible to infection with HIV-1. The World Health Organization estimates that there are 180 million new cases of Trichomonas infection annually worldwide, making it even more prevalent than Chlamydia and gonorrhea, the most common bacterial sexually transmitted infections.
    Description
    The APTIMA Trichomonas vaginalis Assay is an in vitro qualitative nucleic acid amplification test cleared by the FDA for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the TIGRIS DTS System.
    The assay may be used to test specimens from symptomatic or asymptomatic women.
    References
    1. Allsworth J et al.(2009). Trichomoniasis and other Sexually Transmitted Infections: Results from the 2001-2004 National Health and Nutrition Examination Surveys. Sexually transmitted diseases 36: 7238-744
    2. Andrea SB, Chapin KC. J. (2011). Comparison of Aptima Trichomonas vaginalis Transcription-Mediated Amplification Assay and BD Affirm VPIII for Detection of T. vaginalis in Symptomatic Women: Performance Parameters and Epidemiological Implications. Clin Microbiol.49(3):866-9. Epub 2011 Jan 19
    Trademarks
    APTIMA Combo 2 is a trademark of Gen-Probe, Inc.
    ThinPrep is a registered trademark of Cytyc Corporation

    Search Directory

    A-Z Test Listing

    A B C D E F H I J K L M N O P S T U W X Z

    Directory